The West, South and South-East districts reported two instances each, while East, New Delhi, North-East and Shahdara reported one incidence each. No adverse event due to the vaccine was reported from North and South-West districts, an official said.
There has not been any death due to Covid-19 vaccination in Delhi yet. The incidence of adverse events in the country is reported to be 0.18%.
On Saturday, Monday, Tuesday and Wednesday, the number of adverse events reported in Delhi stood at 52, 26, 16 and 26, respectively, of which one or two people required hospitalisation. They were discharged once their condition stabilised.
The country is using two types of vaccines — Covaxin, which has been developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Covishield, which has been developed by Oxford/Astrazeneca in collaboration with Serum Institute of India.
“Adverse events do occur, but they are rare. The vaccines approved for emergency use are safe and people should embrace them to end this pandemic,” said an Delhi government official.